SEPN
Septerna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.75
−0.14%Aug 15, 2026, 03:45 UTC
RA Capital Management, L.P., a significant shareholder and director of Septerna, Inc., sold 1,493,000 shares of Septerna common stock for $63,452,500 on August 12, 2026.
Source:Aug 10, 2026, 22:11 UTC
Septerna, Inc. reported a second-quarter net loss of $0.29 per share, beating the Zacks Consensus Estimate of a $0.48 loss and improving from a $0.56 loss a year earlier.
Source: